InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nkarta, Inc.

NKTX Clue Score29
United States Fiscal year ends December CIK 0001787400
$2.25 +1.35% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.25 −87.69% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Jul 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue0.1Operating income−22.3Net income−21.1Fiscal year 2020Operating income−51.5Net income−91.4Fiscal year 2021Operating income−86.4Net income−86.1EPS, diluted−2.62Fiscal year 2022Operating income−119.0Net income−113.8EPS, diluted−2.61Fiscal year 2023Operating income−131.7Net income−117.5EPS, diluted−2.40Fiscal year 2024Revenue0.0Operating income−128.2Net income−108.8EPS, diluted−1.60Fiscal year 2025Revenue0.0Operating income−122.0Net income−104.1EPS, diluted−1.41
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 n/a n/a n/a n/a 0.0 0.0
Growth
Operating income −22.3 −51.5 −86.4 −119.0 −131.7 −128.2 −122.0
Net income −21.1 −91.4 −86.1 −113.8 −117.5 −108.8 −104.1
Growth
EPS, diluted n/a n/a −2.62 −2.61 −2.40 −1.60 −1.41
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−19,433.9%Net margin−18,327.0%Free cash flow margin−17,647.8%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −19,433.9% n/a n/a n/a n/a n/a n/a
Net margin −18,327.0% n/a n/a n/a n/a n/a n/a
Free cash flow margin −17,647.8% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−18.4Capital expenditure−1.9Free cash flow−20.3Fiscal year 2020Operating cash flow−43.5Capital expenditure−7.5Free cash flow−51.0Fiscal year 2021Operating cash flow−67.9Capital expenditure−5.0Free cash flow−73.0Fiscal year 2022Operating cash flow−57.0Capital expenditure−47.1Free cash flow−104.1Fiscal year 2023Operating cash flow−86.2Capital expenditure−28.1Free cash flow−114.3Fiscal year 2024Operating cash flow−99.7Capital expenditure−4.4Free cash flow−104.1Fiscal year 2025Operating cash flow−88.7Capital expenditure−1.2Free cash flow−89.9
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −18.4 −43.5 −67.9 −57.0 −86.2 −99.7 −88.7
Capital expenditure −1.9 −7.5 −5.0 −47.1 −28.1 −4.4 −1.2
Free cash flow −20.3 −51.0 −73.0 −104.1 −114.3 −104.1 −89.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash20.6Shareholders’ equity−25.5Fiscal year 2020Cash96.7Shareholders’ equity321.2Fiscal year 2021Cash60.8Shareholders’ equity251.0Fiscal year 2022Cash37.5Shareholders’ equity372.2Fiscal year 2023Cash31.0Shareholders’ equity273.3Fiscal year 2024Cash27.9Shareholders’ equity408.0Fiscal year 2025Cash39.6Shareholders’ equity312.3
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 20.6 96.7 60.8 37.5 31.0 27.9 39.6
Shareholders’ equity −25.5 321.2 251.0 372.2 273.3 408.0 312.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−18.4 −43.5 −67.9 −57.0 −86.2 −99.7 −88.7
Growth
0.4 0.8 1.8 2.6 5.9 9.2 9.2
Investment
−1.9 −7.5 −5.0 −47.1 −28.1 −4.4 −1.2
calc −20.3 −51.0 −73.0 −104.1 −114.3 −104.1 −89.9
Growth
calc n/a n/a −2.22 −2.39 −2.33 −1.53 −1.22
−18.3 −210.1 32.5 −184.7 79.0 −129.6 100.3
Financing
49.6 329.8 1.2 219.0 0.7 226.1 0.1

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.